Global Latent Tuberculosis Infection (LTBI) Testing Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Latent Tuberculosis Infection (LTBI) Testing Revenue
• 1.4 Covid-19 Implications on Market by Type
  • 1.4.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Tuberculin Skin Test (TST)
  • 1.4.3 Interferon Gamma Released Assay (IGRA)
• 1.5 Market by Application
  • 1.5.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals and Clinics
  • 1.5.3 Diagnostic Laboratories
  • 1.5.4 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): Latent Tuberculosis Infection (LTBI) Testing Industry Impact
  • 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  • 1.6.2 Covid-19 Impact: Commodity Prices Indices
  • 1.6.3 Covid-19 Impact: Global Major Government Policy
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends

• 2.1 Covid-19 Implications on Global Latent Tuberculosis Infection (LTBI) Testing Market Perspective (2015-2026)
• 2.2 Covid-19 Implications on Global Latent Tuberculosis Infection (LTBI) Testing Growth Trends by Regions
  • 2.2.1 Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Latent Tuberculosis Infection (LTBI) Testing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Latent Tuberculosis Infection (LTBI) Testing Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Latent Tuberculosis Infection (LTBI) Testing Players (Opinion Leaders)

3 Covid-19 Implications on Competition Landscape by Key Players

• 3.1 Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Market Size
  • 3.1.1 Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Revenue (2015-2020)
  • 3.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Ratio
  • 3.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Latent Tuberculosis Infection (LTBI) Testing Revenue in 2019
• 3.3 Latent Tuberculosis Infection (LTBI) Testing Key Players Head office and Area Served
• 3.4 Key Players Latent Tuberculosis Infection (LTBI) Testing Product Solution and Service
• 3.5 Date of Enter into Latent Tuberculosis Infection (LTBI) Testing Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Implications on Market Size by Type (2015-2026)

• 4.1 Global Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Type (2015-2020)
• 4.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Type (2021-2026)

5 Covid-19 Implications on Market Size by Application (2015-2026)

• 5.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)
• 5.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Application (2021-2026)

6 North America Impact of COVID-19

• 6.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
• 6.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in North America (2019-2020)
• 6.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
• 6.4 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

7 Europe Impact of COVID-19

• 7.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
• 7.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Europe (2019-2020)
• 7.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
• 7.4 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

8 China Impact of COVID-19

• 8.1 China Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
• 8.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in China (2019-2020)
• 8.3 China Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
• 8.4 China Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

9 Japan Impact of COVID-19

• 9.1 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
• 9.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Japan (2019-2020)
• 9.3 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
• 9.4 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

10 Southeast Asia Impact of COVID-19

• 10.1 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
• 10.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
• 10.4 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

11 India Impact of COVID-19

• 11.1 India Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
• 11.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in India (2019-2020)
• 11.3 India Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
• 11.4 India Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

12 Central & South America Impact of COVID-19

• 12.1 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
• 12.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
• 12.4 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

13Key Players Profiles

• 13.1 Qiagen
  • 13.1.1 Qiagen Company Details
  • 13.1.2 Qiagen Business Overview and Its Total Revenue
  • 13.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Introduction
  • 13.1.4 Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020))
  • 13.1.5 Qiagen Recent Development and Reaction to COVID-19
• 13.2 Sanofi
  • 13.2.1 Sanofi Company Details
  • 13.2.2 Sanofi Business Overview and Its Total Revenue
  • 13.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Introduction
  • 13.2.4 Sanofi Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
  • 13.2.5 Sanofi Recent Development and Reaction to COVID-19
• 13.3 Oxford Immunotec
  • 13.3.1 Oxford Immunotec Company Details
  • 13.3.2 Oxford Immunotec Business Overview and Its Total Revenue
  • 13.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Introduction
  • 13.3.4 Oxford Immunotec Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
  • 13.3.5 Oxford Immunotec Recent Development and Reaction to COVID-19
• 13.4 Thermo Fisher Scientific
  • 13.4.1 Thermo Fisher Scientific Company Details
  • 13.4.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
  • 13.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Introduction
  • 13.4.4 Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
  • 13.4.5 Thermo Fisher Scientific Recent Development and Reaction to COVID-19
• 13.5 Par Sterile
  • 13.5.1 Par Sterile Company Details
  • 13.5.2 Par Sterile Business Overview and Its Total Revenue
  • 13.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Introduction
  • 13.5.4 Par Sterile Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
  • 13.5.5 Par Sterile Recent Development and Reaction to COVID-19
• 13.6 Bio-Rad Laboratories
  • 13.6.1 Bio-Rad Laboratories Company Details
  • 13.6.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
  • 13.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Introduction
  • 13.6.4 Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
  • 13.6.5 Bio-Rad Laboratories Recent Development and Reaction to COVID-19

14Analyst's Viewpoints/Conclusions

15Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer